SG EFF. PUT24 E2Z Share Price

Warrant

K6208

DE000SU1L414

Real-time Bid/Ask 08:04:12 17/06/2024 BST
0.01 EUR / 0.03 EUR -33.33% Intraday chart for SG EFF. PUT24 E2Z
1 month-25.00%
3 months-76.92%
Date Price Change
14/06/24 0.03 0.00%
13/06/24 0.03 0.00%
12/06/24 0.03 0.00%
11/06/24 0.03 0.00%
10/06/24 0.03 +50.00%

Delayed Quote BME

Last update June 14, 2024 at 04:30 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying ALMIRALL, S.A.
IssuerLogo Issuer Société Générale Société Générale
K6208
ISINDE000SU1L414
Date issued 07/11/2023
Maturity 21/06/2024 (5 Days)
Parity 2 : 1
Emission price 0.22
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 0.24
Lowest since issue 0.02
Spread 0.02
Spread %66.67%

Company Profile

Almirall SA is a Spain-based company principally engaged in the pharmaceuticals manufacture. The Company focuses on development and marketing of drugs applied in various therapeutic areas, such as nervous system, gastrointestinal, dermatological, respiratory system, antiinfectives, as well as antineoplastic and immunomodulating agents. The Company's activities are divided into four business segments: Own network, which focuses on the commercialization of pharmaceuticals through own brand names; Licenses, which sells product rights to third parties; Research and development (R&D), which is responsible for the creation of drug candidates, as well as Dermatology, which includes sale of dermatological medicines in the United States. The Company operates through numerous subsidiaries in Europe, the Americas, Africa, Asia and Australia.
Sector
-
More about the company

Ratings for Almirall, S.A.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Almirall, S.A.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
9.855 EUR
Average target price
11.46 EUR
Spread / Average Target
+16.32%
Consensus
  1. Stock Market
  2. Warrants
  3. K6208 Warrant
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW